Opportunities center on animal-free testing, cancer research, drug discovery, toxicity screening, stem cell research and tissue engineering. High-potential technologies include scaffolds, bioreactors, ...

U.S. High Content Screening Market to Reach USD 1.22 Billion and Europe USD 0.97 Billion by 2035, Supported by AI-Powered ...

Regulators are steering drug testing away from animals, and the systems stepping in each capture only a slice of a living body.

Induced pluripotent stem cells (iPSCs) have transformed research in regenerative medicine, disease modelling, drug discovery, and personalised medicine. But anyone who has worked with iPSCs knows the ...

Research and drug discovery are undergoing a transformation, driven by the rise of 3D cell culture models that better replicate human biology. Unlike traditional 2D cultures and animal models, which ...

Creative Biolabs, a premier provider of 3D biology and preclinical research solutions, today announced the expansion of its specialized primary immune cell catalog.

Atelerix, a biotech company revolutionizing cell preservation and biological transport with its pioneering hydrogel encapsulation technology, today announced the launch of STORganoid ™, an ...

SYDNEY--(BUSINESS WIRE)--Inventia Life Science, an innovator in 3D cell culture technologies, announces the launch of RASTRUM™ Allegro, a groundbreaking advancement in 3D cell culture technology ...

This article is based on a poster originally authored by D. Cole and N. Bevan. 3D models, including spheroids and organoids, are increasingly used to investigate disease and development. Developing, ...

3D cell cultures are no longer a futuristic idea. They’re already reshaping how we study diseases like cancer, offering more realistic models of how cells behave in the body. But despite their ...